Subtracting Rx Adds To Perrigo OTC Pipeline

In deal with Altaris Capital, “I don't feel like we got out at any cost,” says Perrigo CEO Murray Kessler. Agreement calls for “a number of mutual long-term relationship components ... including on Rx-to-OTC switches."

Divesting its Rx generics business took a disproportionate amount of time considering Perrigo Company PLC’s been operating for more than 130 years and it’s been in the prescription drug space for around 15 years.

Still, with the deal with Altaris Capital Partners LLC announced on 1 March, “I don't feel like we got out...

HBW Podcast

Explore how consumer health is evolving. On the go.

David Ridley hosts in-depth conversations with industry leaders.

More from International

More from Geography